Postoperative serum tumor markers-based nomogram predicting early recurrence for patients undergoing radical resections of pancreatic ductal adenocarcinoma

doi:10.4240/wjgs.v16.i10.3211

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1089)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

HTML

655

Figures (1-4)

113

Tables (1-5)

140

Sum=942

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=108

Oct 27, 2024 (publication date) through Jan 31, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Oct 27, 2024; 16(10): 3211-3223
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3211

Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival plot analysis of recurrence free survivals in early recurrence and delayed recurrence group. Patients with early recurrence had significantly poorer recurrence free survival than those with delayed recurrence. RFS: Recurrence free survival; ER: Early recurrence; DR: Delayed recurrence.

Citation: He H, Zou CF, Yang F, Di Y, Jin C, Fu DL. Postoperative serum tumor markers-based nomogram predicting early recurrence for patients undergoing radical resections of pancreatic ductal adenocarcinoma. World J Gastrointest Surg 2024; 16(10): 3211-3223
URL: https://www.wjgnet.com/1948-9366/full/v16/i10/3211.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i10.3211